Market Research Logo

TheraDiag SA (ALTER) - Product Pipeline Analysis, 2016 Update

Summary

Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA is a biotechnology company that develops, manufactures, and markets in-vitro diagnostic products. The company provides product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company offers services in the autoimmune disease diagnostic market. Theradiag is headquartered in Marne LA Vallee, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company TheraDiag SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


TheraDiag SA Company Overview
TheraDiag SA Company Snapshot
TheraDiag SA Pipeline Products and Clinical Trials Overview
TheraDiag SA – Pipeline Analysis Overview
Key Facts
TheraDiag SA - Major Products and Services
TheraDiag SA Pipeline Products by Development Stage
TheraDiag SA Pipeline Products Overview
Companion Diagnostic Assay - Diabetes
Companion Diagnostic Assay - Diabetes Product Overview
Companion Diagnostic Assay - HIV/AIDS
Companion Diagnostic Assay - HIV/AIDS Product Overview
Diagnostic Kit - Autoimmune Disease
Diagnostic Kit - Autoimmune Disease Product Overview
HIV Tropism Test
HIV Tropism Test Product Overview
LTA001 LISA-TRACKER Premium Adalimumab
LTA001 LISA-TRACKER Premium Adalimumab Product Overview
LTA002 LISA-TRACKER Adalimumab
LTA002 LISA-TRACKER Adalimumab Product Overview
LTA003 LISA-TRACKER Anti-Adalimumab
LTA003 LISA-TRACKER Anti-Adalimumab Product Overview
LTA005 LISA-TRACKER Duo Adalimumab
LTA005 LISA-TRACKER Duo Adalimumab Product Overview
LTB002 LISA-TRACKER Bevacizumab
LTB002 LISA-TRACKER Bevacizumab Product Overview
LTB005 LISA-TRACKER Duo Bevacizumab
LTB005 LISA-TRACKER Duo Bevacizumab Product Overview
LTC001 LISA-TRACKER Premium Certolizumab
LTC001 LISA-TRACKER Premium Certolizumab Product Overview
LTC002 LISA-TRACKER Certolizumab
LTC002 LISA-TRACKER Certolizumab Product Overview
LTC003 LISA-TRACKER Anti-Certolizumab
LTC003 LISA-TRACKER Anti-Certolizumab Product Overview
LTC005 LISA-TRACKER Duo Certolizumab
LTC005 LISA-TRACKER Duo Certolizumab Product Overview
LTE001 LISA-TRACKER Premium Etanercept
LTE001 LISA-TRACKER Premium Etanercept Product Overview
LTE002 LISA-TRACKER Etanercept
LTE002 LISA-TRACKER Etanercept Product Overview
LTE003 LISA-TRACKER Anti-Etanercept
LTE003 LISA-TRACKER Anti-Etanercept Product Overview
LTE005 LISA-TRACKER Duo Etanercept Assay
LTE005 LISA-TRACKER Duo Etanercept Assay Product Overview
LTG002 LISA-TRACKER Golimumab
LTG002 LISA-TRACKER Golimumab Product Overview
LTG003 LISA-TRACKER Anti-Golimumab
LTG003 LISA-TRACKER Anti-Golimumab Product Overview
LTG005 LISA-TRACKER Duo Golimumab Assay
LTG005 LISA-TRACKER Duo Golimumab Assay Product Overview
LTI001 LISA-TRACKER Premium Infliximab
LTI001 LISA-TRACKER Premium Infliximab Product Overview
LTI002 LISA-TRACKER Infliximab Assay
LTI002 LISA-TRACKER Infliximab Assay Product Overview
LTI003 LISA-TRACKER Anti-Infliximab Assay
LTI003 LISA-TRACKER Anti-Infliximab Assay Product Overview
LTI005 LISA-TRACKER Duo Infliximab Assay
LTI005 LISA-TRACKER Duo Infliximab Assay Product Overview
LTR002 LISA-TRACKER Rituximab
LTR002 LISA-TRACKER Rituximab Product Overview
LTR003 LISA-TRACKER Anti-Rituximab Assay
LTR003 LISA-TRACKER Anti-Rituximab Assay Product Overview
LTR005 LISA-TRACKER Duo Rituximab
LTR005 LISA-TRACKER Duo Rituximab Product Overview
LTT002 LISA TRACKER Tocilizumab Assay
LTT002 LISA TRACKER Tocilizumab Assay Product Overview
LTT003 LISA TRACKER Anti-Tocilizumab Assay
LTT003 LISA TRACKER Anti-Tocilizumab Assay Product Overview
LTT004 LISA-TRACKER TNFalpha Assay
LTT004 LISA-TRACKER TNFalpha Assay Product Overview
LTT005 LISA-TRACKER Duo Tocilizumab Assay
LTT005 LISA-TRACKER Duo Tocilizumab Assay Product Overview
LTTR002 LISA-TRACKER Trastuzumab Assay
LTTR002 LISA-TRACKER Trastuzumab Assay Product Overview
LTTR003 LISA-TRACKER Anti-Trastuzumab Assay
LTTR003 LISA-TRACKER Anti-Trastuzumab Assay Product Overview
LTTR005 LISA-TRACKER Duo Trastuzumab Assay
LTTR005 LISA-TRACKER Duo Trastuzumab Assay Product Overview
LTU002 LISA-TRACKER Ustekinumab Assay
LTU002 LISA-TRACKER Ustekinumab Assay Product Overview
LTU003 LISA-TRACKER Anti-Ustekinumab Assay
LTU003 LISA-TRACKER Anti-Ustekinumab Assay Product Overview
LTU005 LISA-TRACKER Duo-Ustekinumab Assay
LTU005 LISA-TRACKER Duo-Ustekinumab Assay Product Overview
microRNA Theranostic Test - Autoimmune Disease
microRNA Theranostic Test - Autoimmune Disease Product Overview
microRNA Theranostic Test - Colorectal Cancer
microRNA Theranostic Test - Colorectal Cancer Product Overview
microRNA Theranostic Test - Colorectal Cancer Clinical Trial
Non-invasive Theranostics Test - Metastatic Recurrence
Non-invasive Theranostics Test - Metastatic Recurrence Product Overview
Non-invasive Theranostics Test - Radiochemotherapy
Non-invasive Theranostics Test - Radiochemotherapy Product Overview
TheraDiag Diagnostic Assay - HIV Infection
TheraDiag Diagnostic Assay - HIV Infection Product Overview
TheraDiag SA - Key Competitors
TheraDiag SA - Key Employees
TheraDiag SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
TheraDiag SA, Recent Developments
Dec 01, 2016: US Launch Of The Fifth Test In The LISA TRACKER Range
Oct 13, 2016: THERADIAG: Very strong revenue growth at end-September 2016: +31%
Sep 14, 2016: THERADIAG: First-half 2016 Revenues and Results
Sep 05, 2016: LISA TRACKER chosen by Janssen Biotech for its program to Monitor Patients Treated with Remicade in the USA
Jul 11, 2016: Vincent Fert appointed to Theradiag’s Board of Directors
Jul 11, 2016: THERADIAG Appoints Vincent Fert to Theradiag’s Board of Directors
Jul 05, 2016: Theradiag: Very strong revenue growth in the first half of 2016: +36%
Jun 16, 2016: LISA TRACKER launched in the US market
Apr 25, 2016: Theradiag: First-quarter 2016 revenues up 50%
Apr 06, 2016: Launch of a new fully automated diagnostics system
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
TheraDiag SA Pipeline Products and Clinical Trials Overview
TheraDiag SA Pipeline Products by Equipment Type
TheraDiag SA Pipeline Products by Indication
TheraDiag SA Clinical Trials by Trial Status
TheraDiag SA, Key Facts
TheraDiag SA, Major Products and Services
TheraDiag SA Number of Pipeline Products by Development Stage
TheraDiag SA Pipeline Products Summary by Development Stage
TheraDiag SA Clinical Trials Summary
Companion Diagnostic Assay - Diabetes - Product Status
Companion Diagnostic Assay - Diabetes - Product Description
Companion Diagnostic Assay - HIV/AIDS - Product Status
Companion Diagnostic Assay - HIV/AIDS - Product Description
Diagnostic Kit - Autoimmune Disease - Product Status
Diagnostic Kit - Autoimmune Disease - Product Description
HIV Tropism Test - Product Status
HIV Tropism Test - Product Description
LTA001 LISA-TRACKER Premium Adalimumab - Product Status
LTA001 LISA-TRACKER Premium Adalimumab - Product Description
LTA002 LISA-TRACKER Adalimumab - Product Status
LTA002 LISA-TRACKER Adalimumab - Product Description
LTA003 LISA-TRACKER Anti-Adalimumab - Product Status
LTA003 LISA-TRACKER Anti-Adalimumab - Product Description
LTA005 LISA-TRACKER Duo Adalimumab - Product Status
LTA005 LISA-TRACKER Duo Adalimumab - Product Description
LTB002 LISA-TRACKER Bevacizumab - Product Status
LTB002 LISA-TRACKER Bevacizumab - Product Description
LTB005 LISA-TRACKER Duo Bevacizumab - Product Status
LTB005 LISA-TRACKER Duo Bevacizumab - Product Description
LTC001 LISA-TRACKER Premium Certolizumab - Product Status
LTC001 LISA-TRACKER Premium Certolizumab - Product Description
LTC002 LISA-TRACKER Certolizumab - Product Status
LTC002 LISA-TRACKER Certolizumab - Product Description
LTC003 LISA-TRACKER Anti-Certolizumab - Product Status
LTC003 LISA-TRACKER Anti-Certolizumab - Product Description
LTC005 LISA-TRACKER Duo Certolizumab - Product Status
LTC005 LISA-TRACKER Duo Certolizumab - Product Description
LTE001 LISA-TRACKER Premium Etanercept - Product Status
LTE001 LISA-TRACKER Premium Etanercept - Product Description
LTE002 LISA-TRACKER Etanercept - Product Status
LTE002 LISA-TRACKER Etanercept - Product Description
LTE003 LISA-TRACKER Anti-Etanercept - Product Status
LTE003 LISA-TRACKER Anti-Etanercept - Product Description
LTE005 LISA-TRACKER Duo Etanercept Assay - Product Status
LTE005 LISA-TRACKER Duo Etanercept Assay - Product Description
LTG002 LISA-TRACKER Golimumab - Product Status
LTG002 LISA-TRACKER Golimumab - Product Description
LTG003 LISA-TRACKER Anti-Golimumab - Product Status
LTG003 LISA-TRACKER Anti-Golimumab - Product Description
LTG005 LISA-TRACKER Duo Golimumab Assay - Product Status
LTG005 LISA-TRACKER Duo Golimumab Assay - Product Description
LTI001 LISA-TRACKER Premium Infliximab - Product Status
LTI001 LISA-TRACKER Premium Infliximab - Product Description
LTI002 LISA-TRACKER Infliximab Assay - Product Status
LTI002 LISA-TRACKER Infliximab Assay - Product Description
LTI003 LISA-TRACKER Anti-Infliximab Assay - Product Status
LTI003 LISA-TRACKER Anti-Infliximab Assay - Product Description
LTI005 LISA-TRACKER Duo Infliximab Assay - Product Status
LTI005 LISA-TRACKER Duo Infliximab Assay - Product Description
LTR002 LISA-TRACKER Rituximab - Product Status
LTR002 LISA-TRACKER Rituximab - Product Description
LTR003 LISA-TRACKER Anti-Rituximab Assay - Product Status
LTR003 LISA-TRACKER Anti-Rituximab Assay - Product Description
LTR005 LISA-TRACKER Duo Rituximab - Product Status
LTR005 LISA-TRACKER Duo Rituximab - Product Description
LTT002 LISA TRACKER Tocilizumab Assay - Product Status
LTT002 LISA TRACKER Tocilizumab Assay - Product Description
LTT003 LISA TRACKER Anti-Tocilizumab Assay - Product Status
LTT003 LISA TRACKER Anti-Tocilizumab Assay - Product Description
LTT004 LISA-TRACKER TNFalpha Assay - Product Status
LTT004 LISA-TRACKER TNFalpha Assay - Product Description
LTT005 LISA-TRACKER Duo Tocilizumab Assay - Product Status
LTT005 LISA-TRACKER Duo Tocilizumab Assay - Product Description
LTTR002 LISA-TRACKER Trastuzumab Assay - Product Status
LTTR002 LISA-TRACKER Trastuzumab Assay - Product Description
LTTR003 LISA-TRACKER Anti-Trastuzumab Assay - Product Status
LTTR003 LISA-TRACKER Anti-Trastuzumab Assay - Product Description
LTTR005 LISA-TRACKER Duo Trastuzumab Assay - Product Status
LTTR005 LISA-TRACKER Duo Trastuzumab Assay - Product Description
LTU002 LISA-TRACKER Ustekinumab Assay - Product Status
LTU002 LISA-TRACKER Ustekinumab Assay - Product Description
LTU003 LISA-TRACKER Anti-Ustekinumab Assay - Product Status
LTU003 LISA-TRACKER Anti-Ustekinumab Assay - Product Description
LTU005 LISA-TRACKER Duo-Ustekinumab Assay - Product Status
LTU005 LISA-TRACKER Duo-Ustekinumab Assay - Product Description
microRNA Theranostic Test - Autoimmune Disease - Product Status
microRNA Theranostic Test - Autoimmune Disease - Product Description
microRNA Theranostic Test - Colorectal Cancer - Product Status
microRNA Theranostic Test - Colorectal Cancer - Product Description
microRNA Theranostic Test - Colorectal Cancer - microRNA Signature Predicting a Subject’s Therapeutic Response in Locally Advanced Rectal Cancer
Non-invasive Theranostics Test - Metastatic Recurrence - Product Status
Non-invasive Theranostics Test - Metastatic Recurrence - Product Description
Non-invasive Theranostics Test - Radiochemotherapy - Product Status
Non-invasive Theranostics Test - Radiochemotherapy - Product Description
TheraDiag Diagnostic Assay - HIV Infection - Product Status
TheraDiag Diagnostic Assay - HIV Infection - Product Description
TheraDiag SA, Key Employees
TheraDiag SA, Subsidiaries
List of Figures
TheraDiag SA Pipeline Products by Equipment Type
TheraDiag SA Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report